Veeda Clinical Research Unlisted Shares

BUY AT INR 545.0

Login To Buy Now
★★★★★ 1/5
  • DRHP: Not Filed

Key Indicators

KEY INDICATORS
2024
FACE VALUE/SHARE
10.0
BOOK VALUE/SHARE
141.8
PRICE TO EARNING (PE)
962.3
PRICE/SALES
10.9
PRICE/BOOK
3.6
OUTSTANDING SHARES (Million)
62.9
MARKET CAP (Rs. Million)
32079.0
DEBT/EQUITY
0.2
DIVIDEND/SHARE
0.0
DIVIDEND % (ON CMP)
0.0%
RETURN ON TOTAL ASSETS
0.3%
RETURN ON EQUITY
0.3%
ROWC
4.6%

* Ratio is calculated based on latest financial & current share price.

About The Company

Veeda Clinical Research Ltd. was established in 2004 by a team of experienced medical science professionals with a vision to set up a premium CRO known for its Independence, technical edge, scientific know-how, and better foresight for a clinical trial, an objective of becoming a catalyst for enhanced drug development.
Read More

Pricing Trend

Financials

Revenue Growth %

EBDITA Margin %

EPS Growth %

Profit & Loss Summary

(All Amount in INR Millions)

PROFIT & LOSS
2024
2023
2022
2021
PROFIT & LOSS
2024
2023
2022
REVENUE
2930
3113
2931
2343
REVENUE
2930
3113
2931
EXPENSE
2474
2470
2098
1291
EXPENSE
2474
2470
2098
EBDITA
456
643
833
1052
EBDITA
456
643
833
OTHER COST
409
288
177
200
OTHER COST
409
288
177
PBT
47
355
656
852
PBT
47
355
656
TAX EXPENSE
16
111
155
222
TAX EXPENSE
16
111
155
PAT
31
244
501
630
PAT
31
244
501
OTHER INCOME/EXP.
-1
-4
3
-1
OTHER INCOME/EXP.
-1
-4
3
INCOME (NET OF TAXES)
30
240
504
629
INCOME (NET OF TAXES)
30
240
504
OUTSTANDING SHARE
63
36
36
36
OUTSTANDING SHARE
63
36
36
EPS ( Rs/share)
0.5
7.6
10.3
15.4
EPS ( Rs/share)
0.5
7.6
10.3

Balance Sheet

(All Amount in INR Millions)

BALANCE SHEET
2024
2023
2022
2021
BALANCE SHEET
2024
2023
2022
CASH & CASH EQUIVALENT
206
333
368
150
CASH & CASH EQUIVALENT
206
333
368
NON CURRENT ASSET
7304
4106
4405
1647
NON CURRENT ASSET
7304
4106
4405
CURRENT ASSET
2881
2338
2574
1055
CURRENT ASSET
2881
2338
2574
TOTAL ASSET
10391
6777
7347
2852
TOTAL ASSET
10391
6777
7347
EQUITY SHARE CAPITAL
126
106
106
6
EQUITY SHARE CAPITAL
126
106
106
RESERVES
8794
5109
4523
1688
RESERVES
8794
5109
4523
TOTAL EQUITY
8920
5215
4629
1694
TOTAL EQUITY
8920
5215
4629
NON CURRENT LIABILITY
579
438
908
409
NON CURRENT LIABILITY
579
438
908
CURRENT LIABILITY
892
1124
1810
749
CURRENT LIABILITY
892
1124
1810
TOTAL LIABILITIES
1471
1562
2718
1158
TOTAL LIABILITIES
1471
1562
2718
TOTAL EQUITY & LIABILITY
10391
6777
7347
2852
TOTAL EQUITY & LIABILITY
10391
6777
7347

Cash Flow Summary

(All Amount in INR Millions)

CASH FLOW
2024
2023
2022
2021
CASH FLOW
2024
2023
2022
OPERATING ACTIVITY
205
743
359
766
OPERATING ACTIVITY
205
743
359
INVESTING ACTIVITY
-2291
-1058
-1536
-925
INVESTING ACTIVITY
-2291
-1058
-1536
FINANCING ACTIVITY
1958
81
1626
170
FINANCING ACTIVITY
1958
81
1626
NET CASH FLOW
-128
-234
449
11
NET CASH FLOW
-128
-234
449

Shareholders

Shareholders
Basil Private Limited
All Others
%
69.2
30.8
  • Shareholders Report: Not Filed  

Registered Address

Management

Nitin Deshmukh
Chairman
Mahesh Bhalgat
CEO & Managing Director
Nirmal Bhatia
Company Secretary & Chief Financial Officer

Annual Reports

2024
2023
2022
2021
2020
2019
2018

Quarterly Reports

QR-1
QR-2
QR-3
QR-4

NEWS

Moneycontrol
Veeda Clinical Research: CX Partners-led consortium looks to sell majority stake
Read More
Business Standard
Veeda Clinical Research buys European CRO Heads for an undisclosed sum
Read More
Moneycontrol
Veeda Clinical Research appoints Mahesh Bhalgat as Group CEO
Read More
bl
Veeda Clinical Research acquires 50.1 per cent stake in Bioneeds
Read More
Moneycontrol
Veeda Clinical Research files DRHP for Rs 831.6 crore IPO
Read More
LIVE Mint
Veeda Clinical raises $16 mn from Sabre partners, others
Read More
Load More

NEWS

Pre-IPO market in tizzy as SEBI flags 200-investor cap; merchant bankers look at workarounds
Read More
NSE bonus issue: How to buy and sell unlisted shares?
Read More
MCA tweaks rules; large unlisted private firms have to issue shares in demat forms
Read More
Stockify broadens horizons with Mutual funds and dematerialization of shares
Read More
Piyush Goyal: Had an engaging interaction with leading business leaders in UAE
Read More
Three IPL teams looking to unlock value by public listing, raising PE funds
Read More
Unlisted companies may face tough disclosure rules
Read More
Stockify Fintech reiterates its vow to help HNIs diversify their stock portfolio
Read More
Stockify announces single-window online service to buy unlisted equities
Read More
Stockify expands global reach with participation at Dubai Fintech Summit
Read More
Stockify offers safe, curated and verified Unlisted or Pre-IPO shares to Indians and NRIs
Read More
Back Should retail investors pick IPO shares in pre-market? Key highlights
Read More
Unlisted stocks slump as dull listings, IPOs on hold hit sentiment
Read More
Why Are Pre-IPO Startup Stocks Bleeding In The Unlisted Market?
Read More
Confused About Investing In Unlisted Shares?
Read More
Can I buy unlisted shares using my Zerodha demat account?
Read More
Unlisted Security : Overview, Types, Risks
Read More
India IPO pipeline to continue in 2023 despite global uncertainty
Read More
Stockify announces single-window online service to buy unlisted equities
Read More
Serum Institute, Byju's, NSE among India's top 10 unlisted companies
Read More
Budget 2023: What are the pre-budget expectations for unlisted markets?
Read More
Should you invest in unlisted equities during a bull run
Read More
Stockify Wealth rechristened Stockify Fintech; To help HNIs diversify their stock portfolio
Read More
Budget 2023: After surcharge cap, PE/VCs seek LTCG parity on both unlisted and listed shares
Read More
Are You Investing In Unlisted Shares? Here’s The Process And Tax Compliances
Read More
Norway wealth fund to consider investing in unlisted equities
Read More
Should investors blindly follow the trend and invest in unlisted shares?
Read More
Load More

VIDEO NEWS

Polymatech: Update On New Manufacturing Unit, Expansion & More
Read More
Unlisted companies may face tough disclosure rules
Read More
Load More

Latest Articles From The Experts

No data was found
Load More
Read More
SHARE
VISIT
Whatsapp Telegram Facebook Instagram Twitter Linkedin Youtube Pinterest Reddit Phone-alt
© Copyright 2024 Stockify Fintech Pvt. Ltd. All Rights Reserved.
Join Stockify's WhatsApp Community
Stockify Fintech Pvt. Ltd.
X
Stockify Fintech Pvt. Ltd

Provide Email And Download!

DOWNLOAD
X
Stockify Fintech Pvt. Ltd

Provide Email And Download!

Stockify Fintech Pvt. Ltd.

Haven't found what you're looking for?
Speak to an expert.
Book an appointment by clicking on the link below.

Piyush Jhunjhunwala
Piyush Jhunjhunwala
CA, CPA, Ex. PepsiCo, Reckitt, Coty
CEO & Founder
Dubai, UAE.
Whatsapp Calendar-alt
Rahul Khatuwala
Rahul Khatuwala
Ex. Wipro & Finaco Founder
Co-Founder
Bangalore, India.
Whatsapp Calendar-alt